Several papers have reported that ARF1 could promote tumor development and metastasis in other cancer types, including breast cancer (Haines et al., 2014), cervical cancer (Xu and Zhang, 2020), prostate cancer (Davis et al., 2016), head and neck squamous cell carcinoma (Vo-Hoang et al., 2020). This evidence concerns the gene ARF1 and cervical carcinoma.